COVID-19 significantly raises stroke risk

Researchers conducted a metaumbrella review of 34 systematic reviews and 70 studies, uncovering a significant link between COVID-19 severity and increased stroke risk. The review emphasizes the need for further investigation into underlying mechanisms and potential biases.

Biohaven’s troriluzole rejected before FDA review

Biohaven said Thursday it received a refusal-to-file letter from the FDA over its NDA for troriluzole in an announcement that sent its share price down

July 28, 2023

Novartis’ Leqvio cuts LDL levels by 50% over three years: #ESC23

Novartis said that 78.4% of patients in a Phase III met a pre-specified low-density lipoprotein cholesterol target after taking the siRNA cholesterol drug Leqvio for

August 29, 2023

Antibiotic consumption in Europe rebounds to pre-pandemic levels

This year’s European Antibiotic Awareness Day (EAAD) focuses on the targets outlined in the 2023 Council Recommendation to step up efforts in the European Union

November 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.